Hotgen(SH:688068) Sou Hu Cai Jing·2025-05-31 07:22Company Overview - Beijing Hotgen Biotech Co., Ltd. specializes in the production of diagnostic reagents, diagnostic instruments, and biological raw materials, utilizing inner threaded copper tubes and hydrophilic aluminum foil as primary materials, which offer high heat exchange efficiency and strong corrosion resistance [1] - The company has received over 60 honors, including "Beijing Specialized and Innovative Small Giant Enterprise" and "Beijing Enterprise Technology Center," and has been recognized for its research and development achievements with multiple awards [1] Financial Performance - For Q1 2025, the company reported revenue of 93.24 million yuan, a year-on-year decrease of 19.71%, and a net loss of approximately 24 million yuan, reflecting a significant year-on-year decline of 574.96% [2] - The company's gross profit margin stands at 47.27% [2] Shareholder Information - As of March 31, 2025, the number of shareholders for Hotgen Biotech is 6,662, a decrease of 1,793 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares per shareholder [1] Market Valuation - The company's latest closing price is 124.52 yuan, with a market capitalization of 11.544 billion yuan and a price-to-book ratio of 3.87 [1] - The company's PE (TTM) is reported at -52.46, while the industry average PE is 49.65 [2]